Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP904529.RAcMLMsourJiIJAMkR1QapqNurEZX7jua62rE6Bf8hvTY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP904529.RAcMLMsourJiIJAMkR1QapqNurEZX7jua62rE6Bf8hvTY130_assertion type Assertion NP904529.RAcMLMsourJiIJAMkR1QapqNurEZX7jua62rE6Bf8hvTY130_head.
- NP904529.RAcMLMsourJiIJAMkR1QapqNurEZX7jua62rE6Bf8hvTY130_assertion description "[Taken together, our results suggest that Fn14 is a novel therapeutic target and that inhibition of Fn14 combined with 5-FU treatment may be an effective molecular therapeutic strategy to treat 5-FU-resistant gastric cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP904529.RAcMLMsourJiIJAMkR1QapqNurEZX7jua62rE6Bf8hvTY130_provenance.
- NP904529.RAcMLMsourJiIJAMkR1QapqNurEZX7jua62rE6Bf8hvTY130_assertion evidence source_evidence_literature NP904529.RAcMLMsourJiIJAMkR1QapqNurEZX7jua62rE6Bf8hvTY130_provenance.
- NP904529.RAcMLMsourJiIJAMkR1QapqNurEZX7jua62rE6Bf8hvTY130_assertion SIO_000772 24337061 NP904529.RAcMLMsourJiIJAMkR1QapqNurEZX7jua62rE6Bf8hvTY130_provenance.
- NP904529.RAcMLMsourJiIJAMkR1QapqNurEZX7jua62rE6Bf8hvTY130_assertion wasDerivedFrom befree-20150227 NP904529.RAcMLMsourJiIJAMkR1QapqNurEZX7jua62rE6Bf8hvTY130_provenance.
- NP904529.RAcMLMsourJiIJAMkR1QapqNurEZX7jua62rE6Bf8hvTY130_assertion wasGeneratedBy ECO_0000203 NP904529.RAcMLMsourJiIJAMkR1QapqNurEZX7jua62rE6Bf8hvTY130_provenance.